Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Byrnes

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Epilepsia|August 17, 2016
Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trialDavid G Vossler, Robert T Wechsler, Paulette Williams, et al.
Annals of the New York Academy of Sciences|July 18, 2013
Development of lacosamide for the treatment of partial-onset seizuresPamela Doty, David Hebert, Francois-Xavier Mathy, et al.
Seizure|December 4, 2014
Assessment of the effects of lacosamide on sleep parameters in healthy subjectsJ Douglas Hudson, Jeffrey T Guptill, William Byrnes, et al.
Seizure|August 3, 2019
Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures - An open-label trialJose A Ferreira, Jean-Baptiste Le Pichon, Ahmed T Abdelmoity, et al.
Seizure|September 13, 2015
Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trialWendy Waldman Zadeh, Antonio Escartin, William Byrnes, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentJagdev S Sidhu, Maria Luisa Sardu, Marcus A Björnsson, et al.
Epilepsy & Behavior : E&B|August 13, 2016
Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepineKimford J Meador, David W Loring, Alan Boyd, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentRalph P Maguire, William Byrnes, Matthew E Barton, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Epilepsia|August 17, 2016
Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trialDavid G Vossler, Robert T Wechsler, Paulette Williams, et al.
Annals of the New York Academy of Sciences|July 18, 2013
Development of lacosamide for the treatment of partial-onset seizuresPamela Doty, David Hebert, Francois-Xavier Mathy, et al.
Seizure|December 4, 2014
Assessment of the effects of lacosamide on sleep parameters in healthy subjectsJ Douglas Hudson, Jeffrey T Guptill, William Byrnes, et al.
Seizure|August 3, 2019
Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures - An open-label trialJose A Ferreira, Jean-Baptiste Le Pichon, Ahmed T Abdelmoity, et al.
Seizure|September 13, 2015
Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trialWendy Waldman Zadeh, Antonio Escartin, William Byrnes, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentJagdev S Sidhu, Maria Luisa Sardu, Marcus A Björnsson, et al.
Epilepsy & Behavior : E&B|August 13, 2016
Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepineKimford J Meador, David W Loring, Alan Boyd, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentRalph P Maguire, William Byrnes, Matthew E Barton, et al.
Pageof 1